文献速递痛风与晶体性关节病

急诊出院的急性痛风患者阿片类药物处方使用情况

Prescription Opioid Use Among Patients With Acute Gout Discharged From the Emergency Department.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-07-05

本研究基于Lifespan医疗系统电子健康记录,纳入2015年3月至2017年9月急诊或医院出院、主要诊断为痛风的成人患者456例,评估出院时阿片类药物处方频率、剂量和持续时间及相关因素。结果显示129例(28.3%)出院时接受阿片类药物,平均剂量为37.9±17.2 mg吗啡当量,中位持续8天(IQR 5-14);多关节痛风发作、糖尿病及入院前使用阿片类药物者出院时接受阿片类药物的 odds 更高。结论提示尽管存在有效治疗,阿片类药物仍常用于急性痛风管理。

要点

  • 急诊出院的急性痛风患者中28.3%接受阿片类药物处方,约80%为新使用者。
  • 处方平均剂量37.9±17.2 mg吗啡当量,中位持续时间8天(IQR 5-14)。
  • 多关节发作、糖尿病及入院前使用阿片类药物与出院阿片处方 odds 升高相关。

核心结论

  • 尽管存在有效治疗,阿片类药物仍常用于急性痛风管理,提示需关注该人群的阿片类药物使用问题。

主要发现

  • 456例中129例(28.3%)出院时接受阿片类药物,其中约80%为新使用者。
  • 处方平均剂量为37.9±17.2 mg吗啡当量,中位持续时间8天(IQR 5-14)。
  • 多关节痛风发作、糖尿病及入院前使用阿片类药物者出院时接受阿片类药物的 odds 更高。

临床怎么用

  • 风湿免疫科医生应关注急性痛风患者出院时的镇痛方案,优先使用有效且安全的抗炎治疗,减少不必要的阿片类药物处方。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Acute gout is among the most painful inflammatory arthritides and a frequent cause of emergency department (ED) visits. Prescription opioids are the leading contributor to the ongoing opioid epidemic; EDs are often the source of the index prescription. Our aim was to assess the burden of opioid use and factors associated with its use among gout patients discharged from the ED. METHODS: In the electronic health records system of Lifespan Healthcare System (currently contains 2.2 million records), adult gout patients discharged from the ED or hospital were identified using International Classification of Diseases, Ninth Revision or Tenth Revision diagnostic codes. The study period was March 2015 to September 2017, and only patients with a primary diagnosis of gout were included. If a patient was seen multiple times, only the first encounter was included. For these patients, we estimated the frequency, dose, and duration of opioids prescribed. Using multivariable logistic regression, we ascertained the factors associated with increased odds of opioid prescription at discharge among patients with acute gout. RESULTS: Of the 456 patients, 129 (28.3%) received opioids at discharge (~80% were new patients). The average dose of prescription was mean ± SD 37.9 ± 17.2 mg of morphine equivalent for a median duration of 8 days (interquartile range 5-14). We noted that patients with polyarticular gout attack and diabetes mellitus and those taking opioids prior to admission had higher odds of receiving opioids at discharge. CONCLUSION: Despite the availability of effective treatments, opioids are commonly used for the management of acute gout. This study highlights an opportunity to curb the opioid epidemic among gout patients.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Dalal DS, Mbuyi N, Shah I, et al. Prescription Opioid Use Among Patients With Acute Gout Discharged From the Emergency Department. Arthritis Care Res (Hoboken). 2020. PMID: 31267696. doi:10.1002/acr.23928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。